May 17, 2020

Sun Pharma looks to acquire German genetic drug maker

German genetic drug-maker
Sun's billionaire founder
2 min
Sun Pharma looks to acquire German genetic drug maker
Sun Pharmaceutical Industries Ltd said it is looking at buying German genetic drug-maker Stada Arzneimittel AG (SAZ), the news reports said. It is also...

Sun Pharmaceutical Industries Ltd said it is looking at buying German genetic drug-maker Stada Arzneimittel AG (SAZ), the news reports said.

It is also eyeing acquisitions in Europe. For the European deal, Sun Pharma has sought to raise about $1 billion.

The company executives recently toured Europe to meet with the potential targets.

Sun’s billionaire founder, Dilip Shanghavi, has followed a strategy to acquire under- performing or unprofitable companies and merge their operations into Sun Pharma.

India’s largest drug maker by market value said it brought controlling stakes in 10 companies in the past 14 years, including the acquisition of a majority stake in Israel’s Taro Pharmaceutical Industries Ltd.  

Stada Arzneimittel AG fell 6.3% to close at 23.95 euros in Frankfurt trading yesterday, giving the company a market value of 1.4 billion euros ($1.7 billion).

According to an analyst, the acquisition of Stada will be a surprising deal if the Indian company’s main aim is to grow in the U.S.

Sun Pharma has about $297 million of cash reserves and may look at acquisitions to broaden its geographic breadth and enhance its presence in the U.S.

Stada acquired Serbia’s Hemofarm Koncern AD in 2006 for 480 million euros, and the company’s biggest acquisition and part of a push to shift manufacturing capacity as well as sales in Eastern Europe.

Sun Pharma is an international pharmaceutical company based in Mumbai. It manufactures and sells pharmaceutical formulations and APIs in India and U.S. The company offers formulations in therapeutic areas like cardiology, psychiatry, neurology, gastroenterology and diabetology. It also provides APIs comprising of warfarin, carbamazepine, etodolac, and cloraxepate as also anticancers, steroids, peptides, and controlled substances. 

Share article

Jun 17, 2021

Dexcom: changing the lives of people with type 1 diabetes

3 min
British actress Nina Wadia OBE tells us how her son's life has changed since using glucose monitoring system Dexcom

It is estimated that 9.3% of adults around the world are living with type 1 diabetes, which amounts to a total of 463 million people. A further 1.1 million children and adolescents under the age of 20 are living with the condition. 

Unlike the more prevalent type 2 diabetes, where the body still produces insulin and symptoms develop slowly, people with type 1 diabetes need regular insulin injections or pumps, and must monitor their sugar levels frequently. 

In recent years a number of remote glucose monitoring systems have become available that patients can use at home. These work with a sensor, usually placed under the skin, that measures glucose levels every few minutes. This information is then transmitted wirelessly to a device like a smartphone or tablet, which can then be shared with their clinician. 

British actress Nina Wadia's son Aidan, 14, has type 1 diabetes, and has been managing his condition using Dexcom, a glucose monitoring system used by patients all over the world. Here Wadia explains how Dexcom has improved their lives. 

As a parent of someone with type 1 diabetes, what is your day-to-day life like?
Being able to take a breath, think and pivot constantly without getting frustrated becomes an essential mindset because sometimes it feels like each day is determined to be different from the day before. Whatever worked yesterday is going to misfire today. 

Which areas of yours and Aidan’s life are most impacted by diabetes? 
The one thing that you have to fight hard to reclaim is spontaneity, especially when it comes to food and exercise. It’s only when this is taken do you realise how essential each one is. You can be flexible and there are no real limits, but only in the sense that a great athlete can be flexible without limits because they’ve trained super hard to be that way. So we’ve all had to become athletes when it comes to being spontaneous.

How has Dexcom helped you and Aidan? 
Dexcom has brought future science fiction to real life today. The continuous glucose monitoring system is tiny, sits discreetly on his body and gives him a ten-day breather between sensor changes, so it's goodbye finger-pricking seven times daily. 

Dexcom is totally active at a grass roots level and for Diabetes Awareness has pledged to donate £2,000 if #DexcomDiabetesStories and/or #DexcomWarriorStories is shared 200 times! I’ll be sharing more on social media and would love to hear how other families are winning their fights.

Maybe most importantly Dexcom is trying to introduce a reimbursement programme for type 1 diabetes  patients which will give greater access to modern, life changing hi-tech. I want to spread the word on the importance of accessing it through this campaign. 

If you compared your life today with how it was before Aidan was using Dexcom, what has changed? 
It's always working, which lets him take his mind off diabetes for longer stretches. It also lets me get off his back. We both receive alerts so I no longer have to pester him by asking him what his number is, and especially importantly, I don’t have to wake him at night to prick his finger if I’m worried. Dexcom gave us back our sleep!

Share article